ONTARIO AND QUEBEC EXPAND PUBLIC COVERAGE OF REPATHA(R) FOR ELIGIBLE RECENT ACUTE CORONARY SYNDROME PATIENTS

MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...
Cantech Letter

ONTARIO AND QUEBEC EXPAND PUBLIC COVERAGE OF REPATHA® FOR ELIGIBLE RECENT ACUTE CORONARY SYNDROME PATIENTS

Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) for ...
PharmExec

Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers

VESALIUS-CV data supported evolocumab reducing MACE in high-risk primary prevention diabetes over 4.8 years, reinforcing the ...